Oxygen Therapy for Retinal Ischemia

• Status: Withdrawn
• Trial end date: 2020-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators will be using nocturnal normobaric hyperoxia therapy in patients with diagnoses of conditions related to retinal ischemia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beth Israel Deaconess Medical Center

Criteria

Inclusion Criteria:

• Diagnosis of retinal-ischemia related condition

Exclusion Criteria:

• Complicating other ocular condition

• History of smoking or lung conditions